{{Rsnum
|rsid=308379
|Gene=FGF2
|Chromosome=4
|position=122861741
|Orientation=plus
|GMAF=0.3255
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=FGF2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 43.1 | 43.1 | 13.8
| HCB | 46.7 | 37.8 | 15.6
| JPT | 31.8 | 45.5 | 22.7
| YRI | 74.2 | 25.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 46.7 | 37.8 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19456219
|Title=Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}